BrainSpec
PrivateLast Round
Grant
Jul 2, 2021
Total Funding Raised
$1.9M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
BrainSpec operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Grant round in July 2021.
BrainSpec is a health-tech company that provides a web-based software platform using Magnetic Resonance Spectroscopy (MRS) and AI for non-invasive brain chemistry analysis.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BrainSpec Comparables
Compare BrainSpec with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Darmiyan | 79% | |
| Brainreader | 78% | |
| Cortechs.ai | 78% |
For institutional investors. Book with your work email.
BrainSpec Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 2, 2021 | ||||
| Debt | Apr 1, 2020 | ||||
| Seed | Sep 11, 2017 | ||||
| Accelerator | Feb 6, 2017 | ||||
| Grant | Jul 1, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BrainSpec Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Right Side Capital Management | Seed |
| Techstars | Accelerator, Seed |
| Creative Destruction Lab | Seed |
| Tuesday Capital | Seed |
| Massachusetts Life Sciences Center | Grant |
| Dorm Room Fund | Debt, Seed |
| Bacchus Venture Capital | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 87% MoM.
- Aug 15, 2026
Grew 25% QoQ, from 12 to 15 employees.
For institutional investors. Book with your work email.
BrainSpec Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BrainSpec's valuation, stock price, and market status.
Is BrainSpec a public or private company?
BrainSpec is a private company.
What is the current stock price of BrainSpec?
BrainSpec is a private company, so its shares have no public market price. Caplight tracks BrainSpec's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BrainSpec worth (valuation)?
Valuation information for BrainSpec is not publicly available.
Can I buy BrainSpec stock?
BrainSpec shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BrainSpec's last funding round?
BrainSpec's most recent funding round was Grant on July 2, 2021.
Who are the main investors in BrainSpec?
Key investors in BrainSpec include Massachusetts Life Sciences Center.
Will BrainSpec IPO soon?
No public IPO plans have been announced for BrainSpec.
How can I track BrainSpec secondary market activity?
Caplight tracks bids, offers, and trades in BrainSpec's shares on secondary markets.